FERRING PHARMACEUTICALS

Ferring Pharmaceuticals is a global, research-driven biopharmaceutical company headquartered in Saint-Prex, Switzerland, with operations in over 50 countries. The company develops innovative treatments in areas such as reproductive health, gastroenterology, urology, and orthopedics. In 2005, Ferring acquired the global biologics manufacturing operations of Savient Pharmaceuticals, including the rights to Euflexxa, a hyaluronic acid treatment for knee osteoarthritis pain. Today, Euflexxa remains part of Ferring’s orthopedic portfolio, reflecting the company’s commitment to innovative, high-quality specialty care.

Brands: Euflexxa